Biotechnology - Business Finance

Filter

Current filters:

Business Finance

Popular Filters

German stem cell company Vivocell in search for new investors after insolvency

German stem cell company Vivocell in search for new investors after insolvency

15-08-2014

German stem cell technology company Vivocell Biosolutions, based in Langenfeld, has gone into insolvency…

BiotechnologyBusiness FinanceCloningCord bloodDevelopmental biologyFinancialGeneticsGermanyStem cellsVivocell Biosolutions

iBio collaborates with Kanematsu Chemicals to target Japanese market

iBio collaborates with Kanematsu Chemicals to target Japanese market

14-08-2014

USA-based iBio Inc and Japan’s Kanematsu Chemicals, part of Kanematsu Corp have entered into a collaboration…

BiotechnologyBusiness FinanceiBio IncJapanKanematsuLicensingPharmacologyVaccines

TNI BioTech and Hubei Qianjiang link up on cancer drug development

TNI BioTech and Hubei Qianjiang link up on cancer drug development

13-08-2014

US biotech firm TNI BioTech has signed a supplemental agreement with China’s Hubei Qianjiang Pharmaceutical…

BiotechnologyBusiness FinanceChinaHubeiLicensingOncologyQianjiang PharmaceuticalResearchTNI BioTechUSA

Oncothyreon acquires Alpine Biosciences

Oncothyreon acquires Alpine Biosciences

12-08-2014

US biotech firm Oncothyreon says that it has acquired Alpine Biosciences, of Seattle, Washington, a privately…

Alpine BiosciencesBiotechnologyBusiness FinanceImmunotherapyMedicineMergers & AcquisitionsOncologyOncothyreonRare diseasesUSA

Eylea drives Regeneron’s 2nd-qtr to beat expectations

Eylea drives Regeneron’s 2nd-qtr to beat expectations

05-08-2014

USA-based biotech company Regeneron (Nasdaq: REGN) revealed today that total revenues for the second…

BiotechnologyBusiness FinanceEyleaFinancialOphthalmicsRegeneronUSA

Theraclone out-licenses HIV bNAbs to Gilead

Theraclone out-licenses HIV bNAbs to Gilead

01-08-2014

US privately-held drug developer Theraclone Sciences has entered into an agreement with biotech major…

Anti-viralsBiotechnologyBusiness FinanceGilead SciencesHIV/AIDSLicensingTheraclone SciencesUSA

Cellectis sells Swedish subsidiary to Japan’s Takara Bio

30-07-2014

France-based genome engineering specialist Cellectis says it has sold its Swedish subsidiary Cellectis…

BiotechnologyBusiness FinanceCellectisCellectis ABFranceMergers & AcquisitionsTakara Bio

Gilead beats forecasts as Sovaldi sales soar

Gilead beats forecasts as Sovaldi sales soar

24-07-2014

US anti-virals specialist biotech firm Gilead Sciences has reported surging second-quarter 2014 sales…

Anti-viralsBiotechnologyBusiness FinanceBusiness FinanceChemistryFinancialFixed dose combinationGilead SciencesSovaldiTenofovir

Charles Ramat and Paul Freiman named co-chief executive of Neurotrope

Charles Ramat and Paul Freiman named co-chief executive of Neurotrope

21-07-2014

US-based Neurotrope, developers of diagnostic and therapeutic technologies for the treatment of neurodegenerative…

BiotechnologyBoardroomBusiness FinanceCo-chiefDiagnostic and therapeutic technologiesNeurologicalNeurotropePermanent chief executiveSyntexUSA

Partnerships in Latin America big business between 2009 and 2013

Partnerships in Latin America big business between 2009 and 2013

18-07-2014

Traditional partnerships (excluding mergers, acquisitions and early venture funding) where a Latin American…

BiotechnologyBusiness FinanceFinancialPharmaceuticalSouth America

$25 million milestone for Incyte on Japanese approval of Jakavi

$25 million milestone for Incyte on Japanese approval of Jakavi

08-07-2014

US biopharma company Incyte says it has earned a $25 million milestone payment from Swiss drug major…

BiotechnologyBusiness FinanceBusiness FinanceFinancialIncyteJakaviJapanMajorMedicineNovartisOncologyRegulationRuxolitinib

Vertex leaps on positive Ph III results with lumacaftor

Vertex leaps on positive Ph III results with lumacaftor

24-06-2014

US biotech firm Vertex Pharmaceuticals saw its share price rocket nearly 52% to $101.20 in extending…

BiotechnologyBusiness FinanceCystic fibrosisHealth Medical PharmaKalydecolumacaftorMedicinePhenolsRare diseasesRegulationResearchVertex Pharmaceuticals

Australian biotech survey shows advanced manufacturing heading overseas

Australian biotech survey shows advanced manufacturing heading overseas

12-06-2014

The annual Australian Biotechnology Industry Position Survey (2014) shows a worrying trend: advanced…

AustraliaBiotechnologyBusiness FinanceBusiness FinanceChief executiveFinancialHealthcare in IndiaInnovationPoliticsProduction

China’s API industry is leading world production says new report

China’s API industry is leading world production says new report

05-06-2014

China’s chemical drug preparation industry and active pharmaceutical ingredient (API) industry recorded…

BiotechnologyBusiness FinanceChinaProduction

arGEN-X and Shire sign long term collaboration deal worth $20 million

arGEN-X and Shire sign long term collaboration deal worth $20 million

04-06-2014

Belgium-based preclinical stage biotech firm arGEN-X has entered into a long-term strategic alliance…

arGEN-XBiotechnologyBusiness FinanceEuropeHuman antibody discovery technologiesResearchShireShire Pharmaceuticals

Report shows rise in IPOs revive investments in pharma and biotech

Report shows rise in IPOs revive investments in pharma and biotech

29-05-2014

The heightened private equity and venture capital (PEVC) deal activity in the global health care industry…

BiotechnologyBusiness FinanceFinancialGlobalHealth Medical PharmaPharmaceuticalPharmaceutical industryPharmaceutical sciencesPrivate

Ambrx and Zhejiang Hisun sign deal over cancer treatment

Ambrx and Zhejiang Hisun sign deal over cancer treatment

30-04-2014

USA-based clinical-stage biopharmaceutical company Ambrx and Chinese pharma firm Zhejiang Hisun Pharmaceutical…

AmbrxBiopharmaceuticalBiotechnologyBusiness FinanceChinaHealth Medical PharmaHealth Medical PharmaLicensingOncologyPharmaceutical industryUSA

New report finds upturn in the Swiss biotech sector in 2013

15-04-2014

The Swiss biotech sector saw increases in terms of net sales, capital investments and number of employees,…

BiotechnologyBusiness FinanceBusiness FinanceEnvironmentHelvetiiMarkets & MarketingNorthern EuropeSwitzerland

Back to top